The role of α-interferon in patients with human immunodeficiency virus infectionLANE, H. C.Seminars in oncology. 1991, Vol 18, Num 5, pp 46-52, issn 0093-7754, SUP7Article

Acquired immunodeficiency syndromeLANE, H. C.Dermatologic clinics. 1990, Vol 8, Num 4, pp 771-786, issn 0733-8635, 16 p.Article

Recent advances in the management of AIDS-related opportunistic infectionsLANE, H. C.Annals of internal medicine. 1994, Vol 120, Num 11, pp 945-955, issn 0003-4819Article

Immunoregulation, immune defects, and clinical strategies in HIV infection : Mount Sinai medical centLANE, H. C.The Mount Sinai journal of medicine. 1992, Vol 59, Num 3, pp 244-252, issn 0027-2507Article

Nucleoside triphosphate changes during the peripheral life-span of erythrocytes of adult rainbow trout (Salmo gairdneri)LANE, H. C.The Journal of experimental zoology. 1984, Vol 231, Num 1, pp 57-62, issn 0022-104XArticle

Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppressionORENSTEIN, J. M; BHAT, N; LANE, H. C et al.AIDS (London). 2000, Vol 14, Num 12, pp 1709-1715, issn 0269-9370Article

Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionWALKER, R. E; BECHTEL, C. M; LEITMAN, S. F et al.Blood. 2000, Vol 96, Num 2, pp 467-474, issn 0006-4971Article

Immune reconstitution in HIV infectionGEA-BANACLOCHE, J. C; LANE, H. C.AIDS (Supplement). 1999, Vol 13, Num A, pp S25-S38, issn 1350-2840Article

A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infectionDAVEY, R. T; CHAITT, D. G; DEWAR, R et al.The Journal of infectious diseases. 1999, Vol 179, Num 4, pp 849-858, issn 0022-1899Article

Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisWHITCUP, S. M; FORTIN, E; VRABEC, T et al.JAMA, the journal of the American Medical Association. 1999, Vol 282, Num 17, pp 1633-1637, issn 0098-7484Article

Re-emergence of HIV after stopping therapyCHUN, T.-W; DAVEY, R. T; ENGEL, D et al.Nature (London). 1999, Vol 401, Num 6756, pp 874-875, issn 0028-0836Article

Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virusSPOONER, K. M; LANE, H. C; MASUR, H et al.Clinical infectious diseases. 1996, Vol 23, Num 1, pp 15-27, issn 1058-4838Article

Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumoniaFALLOON, J; LAVELLE, J; KOVACS, J. A et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 7, pp 1580-1587, issn 0066-4804Article

Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteinsTANI, Y; HUAN TIAN; LANE, H. C et al.The Journal of immunology (1950). 1993, Vol 151, Num 12, pp 7337-7348, issn 0022-1767Article

Isolation of HIV-1 from plasma of infected individuals : an analysis of experimental conditions affecting successful virus propagationDEWAR, R. L; SARMIENT, M. D; LAWTON, E. S et al.Journal of acquired immune deficiency syndromes. 1992, Vol 5, Num 8, pp 822-828, issn 0894-9255Article

Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1COHEN, D. I; TANI, Y; HUAN TIAN et al.Science (Washington, D.C.). 1992, Vol 256, Num 5056, pp 542-545, issn 0036-8075Article

Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV)OGNIBENE, F. P; MASUR, H; LANE, H. C et al.Annals of internal medicine. 1988, Vol 109, Num 11, pp 874-879, issn 0003-4819Article

Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsivenessROOK, A. H; KEHRL, J. H; WAKEFIELD, L. M et al.The Journal of immunology (1950). 1986, Vol 136, Num 10, pp 3916-3920, issn 0022-1767Article

Etiology of the acquired immunodeficiency syndromeFAUCI, A. S; LANE, H. C.Advances in host defense mechanisms. 1985, Vol 5, pp 29-34, issn 0732-0566Article

Immunologic reconstitution in the acquired immunodeficiency syndromeLANE, H. C; FAUCI, A. S.Annals of internal medicine. 1985, Vol 103, Num 5, pp 714-718, issn 0003-4819Article

Monocyte function in the acquired immune deficiency syndrome: defective chemotaxisSMITH, P. D; OHURA, K; MASUR, H et al.The Journal of clinical investigation. 1984, Vol 74, Num 6, pp 2121-2128, issn 0021-9738Article

Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen : Pharmacokinetic drug interactions and antiviral activityFALLOON, J; PISCITELLI, S; LANE, H. C et al.Clinical infectious diseases. 2000, Vol 30, Num 2, pp 313-318, issn 1058-4838Article

Atovaquone suspension in HIV-infected volunteers : Pharmacokinetics, pharmacodynamics, and TMP-SMX interaction studyFALLOON, J; SARGENT, S; LANE, H. C et al.Pharmacotherapy. 1999, Vol 19, Num 9, pp 1050-1056, issn 0277-0008Article

Potent activity of 2'-β-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID miceRUXRUNGTHAM, K; BOONE, E; FORD, H. JR et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 10, pp 2369-2374, issn 0066-4804Article

Randomized, controlled phase I/II trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsDAVEY, R. T; CHAITT, D. G; WALKER, R. E et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 7, pp 1657-1664, issn 0066-4804Article